Lantz Financial LLC Novartis Ag Transaction History

Lantz Financial LLC

$351 Million
Q3 2024

A detailed history of Lantz Financial LLC transactions in Novartis Ag stock. As of the latest transaction made, Lantz Financial LLC holds 6,862 shares of NVS stock, worth $712,344. This represents 0.22% of its overall portfolio holdings.

Number of Shares

6,862

Previous 7,061 2.82%

Holding current value

$712,344

Previous $751,000 5.06%

% of portfolio

0.22%

Previous 0.24%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$106.13 - $120.89 $21,119 - $24,057	-199 Reduced 2.82%	6,862 $789,000
Q2 2024 Jul 10, 2024	SELL	$92.57 - $107.37 $12,311 - $14,280	-133 Reduced 1.85%	7,061 $751,000
Q1 2024 Apr 10, 2024	SELL	$95.27 - $108.47 $25,246 - $28,744	-265 Reduced 3.55%	7,194 $695,000
Q4 2023 Jan 12, 2024	BUY	$92.27 - $101.54 $830 - $913	9 Added 0.12%	7,459 $753,000
Q3 2023 Oct 20, 2023	BUY	$94.73 - $105.13 $2,652 - $2,943	28 Added 0.38%	7,450 $758,000
Q2 2023 Jul 12, 2023	SELL	$92.52 - $104.91 $35,527 - $40,285	-384 Reduced 4.92%	7,422 $748,000
Q1 2023 Apr 10, 2023	SELL	$80.03 - $92.81 $19,847 - $23,016	-248 Reduced 3.08%	7,806 $718,000
Q4 2022 Jan 23, 2023	SELL	$75.55 - $92.52 $3,701 - $4,533	-49 Reduced 0.6%	8,054 $0
Q3 2022 Oct 17, 2022	SELL	$74.61 - $87.26 $55,957 - $65,445	-750 Reduced 8.47%	8,103 $616,000
Q2 2022 Jul 29, 2022	SELL	$80.52 - $93.75 $11,192 - $13,031	-139 Reduced 1.55%	8,853 $748,000
Q1 2022 May 05, 2022	BUY	$80.11 - $90.62 $54,955 - $62,165	686 Added 8.26%	8,992 $789,000
Q4 2021 Jan 19, 2022	SELL	$79.7 - $88.13 $14,664 - $16,215	-184 Reduced 2.17%	8,306 $727,000
Q3 2021 Oct 14, 2021	BUY	$81.78 - $95.14 $32,957 - $38,341	403 Added 4.98%	8,490 $694,000
Q2 2021 Jul 16, 2021	SELL	$85.24 - $94.15 $7,330 - $8,096	-86 Reduced 1.05%	8,087 $738,000
Q1 2021 Apr 19, 2021	BUY	$83.5 - $98.47 $6,429 - $7,582	77 Added 0.95%	8,173 $699,000
Q4 2020 Jan 19, 2021	BUY	$78.07 - $94.43 $19,049 - $23,040	244 Added 3.11%	8,096 $765,000
Q3 2020 Oct 09, 2020	BUY	$82.14 - $91.0 $5,914 - $6,552	72 Added 0.93%	7,852 $683,000
Q2 2020 Jul 22, 2020	SELL	$80.93 - $91.1 $129,973 - $146,306	-1,606 Reduced 17.11%	7,780 $680,000
Q1 2020 Apr 10, 2020	BUY	$70.67 - $99.01 $72,860 - $102,079	1,031 Added 12.34%	9,386 $774,000
Q4 2019 Jan 17, 2020	SELL	$84.35 - $95.37 $45,970 - $51,976	-545 Reduced 6.12%	8,355 $791,000
Q3 2019 Oct 18, 2019	SELL	$85.54 - $94.26 $44,309 - $48,826	-518 Reduced 5.5%	8,900 $751,000
Q2 2019 Jul 15, 2019	SELL	$75.4 - $92.8 $13,496 - $16,611	-179 Reduced 1.87%	9,418 $867,000
Q1 2019 Apr 22, 2019	BUY	$75.32 - $86.15 $722,846 - $826,781	9,597 New	9,597 $923,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lantz Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lantz Financial LLC with notifications on news.

Account

Lantz Financial LLC Novartis Ag Transaction History